ACUTE-Acute Surgical Care- Risk Factors and Outcomes for Patients in Need of Acute Surgical Care

NCT ID: NCT05195697

Last Updated: 2023-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-01-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational retrospective study of patients in need of acute surgical care admitted to Skåne University Hospital between 2009 and 2019.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At Skåne University Hospital approximately 6000 individuals are treated for acute abdominal diseases each year. Given the high number of patients, there is an urgent need to optimize acute surgical care. Lower complication rates would decrease hospital stay, health care costs as well as personal suffering.

Assessment instruments for risks and frailty are not validated for the acute setting and the investigators hypothesize there is room for improvement in prophylactic interventions and risk assessment. The investigators will study cohorts of patients with three different surgical diagnosis: acute pancreatitis, gastrointestinal bleeding and perforated ulcer aiming to identify risk factors for complications or death and to investigate assessment tools in this population. Using propensity score analysis, the investigators will try to identify treatment options associated with better outcome for subcohorts defined by frailty, comorbidity, age or gender. Specific factors of interest include: time to- and kind of treatment, handling of ongoing pharmacological therapy (anticoagulants, corticosteroids) and need for further treatments on a long time basis. The results from this project will be used in a future prospective study where prophylactic treatments and specific treatment options are studied.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Risk Factors Complication of Surgical Procedure Complication of Treatment Complication of Anesthesia Long Term Effects After Emergency Surgery Long Term Effects After GI Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mild acute pancreatitis

Patients treated with mild acute pancreatitis during the study period

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Moderate acute pancreatitis

Patients treated with moderate acute pancreatitis during the study period

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Severe acute pancreatitis

Patients treated with severe acute pancreatitis during the study period

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Acute gastrointestinal bleeding

Patients treated with acute gastrointestinal bleeding during the study period

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Perforated ulcer

Patients treated with perforated ulcer during the study period

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Older than 70 years

Patients older than 70 years

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Less than 70 years

Patients younger than 70 years

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Prothrombotic medications

Patients on prothrombotic medications

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Frail patients

Patients with increased frailty score

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Reintervention group

Patients in need of reintervention

Observational study of different treatments and time to treatment

Intervention Type OTHER

Different treatment based on the clinical decision

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational study of different treatments and time to treatment

Different treatment based on the clinical decision

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lund University

OTHER

Sponsor Role collaborator

Region Skane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sara Regnér, PhD

Role: PRINCIPAL_INVESTIGATOR

Region Skåne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Skåne University Hospital

Malmo, Skåne County, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sara Regnér, PhD

Role: CONTACT

040 33 10 00

Jenny Eckner, PhD

Role: CONTACT

040 33 10 00

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sara Regnér, PhD

Role: primary

040 331000

Jenny Eckner, PhD

Role: backup

040 331000

References

Explore related publications, articles, or registry entries linked to this study.

Forsberg-Puckett A, Wurm Johansson G, Regner S. Presentation of gastrointestinal bleeding in patients with antithrombotic therapy, results from a consecutive retrospective cohort. Scand J Trauma Resusc Emerg Med. 2025 Sep 10;33(1):146. doi: 10.1186/s13049-025-01431-1.

Reference Type DERIVED
PMID: 40931336 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-03583

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Children's Acute Surgical Abdomen Programme
NCT04602429 ACTIVE_NOT_RECRUITING